Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Summary of Antidilutive Securities Excluded from Computation of Weighted Average Common Stock Outstanding

The following potentially dilutive shares of common stock have not been included in the computation of diluted net loss per share for all periods as the result would be anti-dilutive:

 

 

 

 

December 31,

 

 

 

 

 

2019

 

 

2018

 

Warrants to purchase Series C-1 Preferred

 

 

 

 

 

 

 

14,033

 

Warrants to purchase common stock associated with Solar loan agreement

 

 

 

 

122,435

 

 

 

122,435

 

Warrants to purchase common stock associated with June 2016 public offering

 

 

 

 

4,218,750

 

 

 

4,218,750

 

Warrants to purchase common stock associated with March 2018 Public Offering - Series 1

 

 

 

 

 

 

 

13,198,075

 

Warrants to purchase common stock associated with March 2018 Public Offering - Series 2

 

 

 

 

7,988,175

 

 

 

7,988,175

 

Outstanding stock options

 

 

 

 

5,261,860

 

 

 

4,052,913

 

Outstanding restricted stock units

 

 

 

 

966,394

 

 

 

111,891

 

Common stock associated with 6% convertible senior notes

 

 

 

 

11,382,000

 

 

 

 

Warrants to purchase common stock associated with December 2019 Public Offering

 

 

 

 

44,722,222

 

 

 

 

Option to purchase common stock associated with December 2019 Public Offering

 

 

 

 

5,833,333

 

 

 

 

          Total

 

 

 

 

80,495,169

 

 

 

29,706,272